Trailing-twelve-month (TTM) revenue is $67.59 Million with a year-over-year growth of +1.89%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $18,388,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $18,857,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $18,585,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-19 |
| Q2 FY2026Period ended 2026-06-30 | $11,760,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $67,590,000 |
Current P/S: $173,744,353 market capitalization ÷ $67,590,000 TTM revenue = 2.57x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:54:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $11.76M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:58:26.053Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20142014-12-31 · USD | FY20152015-12-31 · USD | FY20162016-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| All Other Segments | $3M | $2M | N/A | N/A | N/A | N/A |
| Other (Including Israel) | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $15M | $15M | $13M | $10M | $13M | $10M |
| EMEA | $2M | $3M | $8M | $9M |
$67.59M
$67.59 Million
+1.89%
vs. $66.34M a year ago (TTM)
+11.64%
5 Year compound annual growth rate
1 Year
+1.89%
3 Year
+11.55%
5 Year
+11.64%
10 Year
+12.28%
15 Year
+7.87%
20 Year
+5.48%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $71.49M | +$10.48M | +17.19% |
| 2024 | $61.01M | +$9.41M | +18.23% |
| 2023 | $51.60M | +$5.55M | +12.05% |
| 2022 | $46.05M | +$5.77M | +14.32% |
| 2021 | $40.28M | +$2.72M | +7.24% |
| 2020 |
TTM Growth
+1.89%
3-Year CAGR
+11.55%
5-Year CAGR
+11.64%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:58:26.053Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $802,000 |
| N/A |
| N/A |
| N/A |
| Product | N/A | N/A | N/A | $23M | $28M | $37M |
|---|
| Service | N/A | N/A | N/A | $29M | $33M | $35M |
|---|
| $23M |
| Latin America | $223,000 | $1M | $3M | $1M | $327,000 | $222,000 |
|---|
| North America | $20M | $22M | $23M | $32M | $36M | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | N/A | $39M |
|---|
| $37.56M |
| +$4.55M |
| +13.79% |
| 2019 | $33.01M | ($1.04M) | (3.05%) |
| 2018 | $34.05M | ($3.18M) | (8.55%) |
| 2017 | $37.23M | +$7.72M | +26.17% |
| 2016 | $29.51M | +$10.84M | +58.04% |
